Managing uncontrolled hemorrhage in trauma and surgery: a novel and promising approach.
Hardy JF
Can J Anaesth 2002;49(10):S4-S6.
Review by
Possible role of recombinant activated factor VII (RFVIIa) in the control of hemorrhage associated with massive trauma.
Martinowitz U, Kenet G, Lubetski A, Luboshitz J, Segal E
Can J Anaesth 2002;49(10):S15-S20.
Review by
Efficacy of recombinant factor VIIa administered by continuous infusion to haemophilia patients with inhibitors.
Mauser-Bunschoten EP, Koopman MMW, Goede-Bolder ADE, et al.
Haemophilia 2002;8(5):649-656.
Review by M. Aldouri
The effect of recombinant factor VIIa on coagulopathic pigs with grade V liver injuries.
Schreiber MA, Holcomb JB, Hedner U, Brundage SI, Macaitis JM, Hoots K
J Trauma 2002;53(2):252-257.
Review by Aldouri M
Orthopaedic surgery in haemophilic patients with inhibitors: an overview.
Hvid I, Rodriguez-Merchan EC
Haemophilia 2002;8(3):288-291.
Review by
Continuous infusion of coagulation factor products.
Stachnik JM, Gabay MP
Ann Pharmacother 2002;36(5):882-891.
Review by
Early use of recombinant factor VIIa improves mean arterial pressure and may potentially decrease mortality in experimental hemorrhagic shock: A pilot study.
Lynn M, Jerokhimov I, Jewelewicz D, et al.
J Trauma 2002;52(4):703-707.
Review by
Recombinant factor VIIa in the management of surgery and acute bleeding episodes in children with haemophilia and high responding inhibitors.
O’Connell N, McMahon C, Smith J, et al.
Br J Haematol 2002;116(3):632-635.
Review by Aldouri M
Massive pseudotumour resection with recombinant factor VIIa (NovoSeven) cover.
O’Connell N, Chen J, Byrne M, OShea E, Smyth H, Smith OP
Br J Haematol 2002;116(3):645-648.
Review by
Effective hemostasis with rFVIIa treatment in two patients with severe thrombocytopenia and life-threatening hemorrhage.
Gerotziafas GT, Zervas C, Gavrielidis G, et al.
Am J Hematol 2002;69(3):219-222.
Review by M. Aldouri